HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott's Plan For Similac ‘#1 Pediatrician Recommended’ Label Claim May Have To Wait

Executive Summary

Abbott Nutrition has used ‘#1 Pediatrician Recommended Brands’ claim for Similac on social media and advertising to doctors and planned to add to labeling, but a disclosure doesn’t clarify the statement refers to a combination category and not the product alone, says National Advertising Division.

You may also be interested in...



CRN Ends Funding For Industry Self-Regulation Program Focused On Supplement Advertising

The trade group ends funding for National Advertising Division program launched in 2006 for increased focus on monitoring supplement claims, reviewing 360 in total. Separately, NAD launches an expedited challenge process aiming to conclude reviews in 20 business days.

Enfamil NeuroPro Ingredient Tests Miss, J&J Doubts Mommy's Bliss Claims

Council of Better Business Bureaus' industry self-regulation arm reviews claims for Mead Johnson's s Enfamil NeuroPro infant formula on challenge by Similac marketer Abbott Nutrition. Recent reviews also include ad claims for children's herbal remedies marketed by Mommy’s Blisson challenged by J&J's consumer business.

Edgewell Cuts $310m Billie Deal Without FTC Incident

Acquisition of value-tier, female-first razor firm Billie, Inc. – previously attempted by P&G before the US Federal Trade Commission intervened – will add a youthful, on-message brand to the Schick owner’s women’s shave portfolio. The deal follows Edgewell’s bid to acquire Harry’s in 2020, also thwarted by the FTC.

Topics

Related Companies

UsernamePublicRestriction

Register

RS150533

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel